Caladrius Biosciences (CLBS) Awarded $12.2 Million Grant From CIRM In Support Of Phase II Clinical Trial Of CLBS03 To Treat Type 1 Diabetes
Created:
February 24, 2017
News organization:
BioSpace.com
Link to news item:
News type:
CIRM in the news